Moleculin Biotech
MBRX
MBRX
23 hedge funds and large institutions have $1.78M invested in Moleculin Biotech in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$294K | |
| 2 | +$179K | |
| 3 | +$93.5K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$89.6K |
| 5 |
Truist Financial
Charlotte,
North Carolina
|
+$40.4K |
Top Sellers
| 1 | -$170K | |
| 2 | -$22K | |
| 3 | -$21K | |
| 4 |
VF
Virtu Financial
New York
|
-$13K |
| 5 |
BlackRock
New York
|
-$2.63K |